Davorka Messmer
Principal investigator, leads Talapo Therapeutics.
BiotechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2018First federal award
$1.0MFederal grants as PI4 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
4 awards · $1.0M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 18, 2018 | NIH | SBIR Phase I Targeting TGF-beta growth factors to treat obesity | $290K | Talapo Therapeutics |
| Sep 17, 2018 | NIH | SBIR Phase I Targeting TGF-beta growth factors to treat obesity | $290K | Talapo Therapeutics |
| May 4, 2018 | NIH | SBIR Phase I Cerberus therapy for metastatic disease | $225K | Talapo Therapeutics |
| May 4, 2018 | NIH | SBIR Phase I Cerberus therapy for metastatic disease | $225K | Talapo Therapeutics |
Peer ranks
Federal funding#1,712
Awards as PI#566
Patents#273
Companies
- Talapo TherapeuticsLeads (SEC Form D) · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.